11 results
Checklist for Treatment of Delirium in the ICU 

Remove causative factors 
 - 
Exclude hypoglycemia if
of Delirium in ... c deliriogenic meds ... sleeping, administer pharmacologic ... #Management #Treatment ... #MICU #CriticalCare
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... non-OTC prolonging agent ... No pharmacologic ... #PAD #ICU #CriticalCare ... #diagnosis #management
Diuresis in Critical Care - Achieving a Negative Fluid Balance
Advantages Of A Negative Fluid Balance:
 •
Diuresis in Critical ... REMOVE UNECCESARY MEDS ... aldosterone states (CHF ... Fluid #Balance #management ... #criticalcare
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
have achieved negative ... #table #foamed ... #heartfailure #chf ... #criticalcare # ... icu #clinical #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Immunosuppressive agents ... epilepticus Treatment ... underlying cause • Treatment ... titratable parenteral agents ... Syndrome #diagnosis #management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... , hypokalemia, negative ... #valleyfever #management ... #comparison #table ... #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... , hypokalemia, negative ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
peaks between the ages ... Transverse Myelitis - Clinical ... tested and if negative ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... disease b) CHF ... Change in clinical ... Cataract Plan for Meds ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Clinical • Under-recognized ... May have typical HF ... Delivery • Stable ... teratogenic GDMT meds ... #cardiology #treatment